← All diseases
Brain and nervous system
ALS (amyotrophic lateral sclerosis)
Do you want to receive a message when there is new research about ALS (amyotrophic lateral sclerosis)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was researched — and you receive a message as soon as there is new research about ALS (amyotrophic lateral sclerosis). View what Premium costs.
Publications and studies (2467)
- Occupational lead exposure and survival with amyotrophic lateral sclerosis. (2023/02/01) ♡
- A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018. (2023/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors predicting disease progression in C9ORF72 ALS patients. (2023/02/01) ♡
- Identification of potential pathways and biomarkers linked to progression in ALS. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The roles of fungus in CNS autoimmune and neurodegeneration disorders. (2023/01/26) ♡
- Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire. (2023/01/20) ♡
- Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology. (2023/01/19) ♡
- A DUAL MTOR/NAD+ ACTING GEROTHERAPY. (2023/01/19) ♡
- Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries. (2023/01/17) ♡
- Comprehensive analysis of transcriptomics and metabolomics to understand tail-suspension-induced myocardial injury in rat. (2023/01/17) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Translational study for amyotrophic lateral sclerosis treatment. (2023/01/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. RNA Dysmetabolism and Repeat-Associated Non-AUG Translation in Frontotemporal Lobar Degeneration/Amyotrophic Lateral Sclerosis due to C9orf72 Hexanucleotide Repeat Expansion. (2023/01/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells via circRNAs as a potential therapeutic approach for neurodegenerative diseases. (2023/01/16) ♡
- Diagnostic utility of susceptibility-weighted imaging in amyotrophic lateral sclerosis. (2023/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Split phenomena in amyotrophic lateral sclerosis: Current evidences, pathogenetic hypotheses and diagnostic implications. (2023/01/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons. (2023/01/05) ♡
- Face and content validation of the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI). (2023/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. TARDBP-Related Amyotrophic Lateral Sclerosis-Frontotemporal Dementia. (2023/01/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype. (2023/01/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Motor neuron disease phenotype associated with symptomatic copper deficiency: Challenging diagnosis and treatment. (2023/01/04) ♡
- Comprehensive expression analysis with cell-type-specific transcriptome in ALS-linked mutant SOD1 mice: Revisiting the active role of glial cells in disease. (2023/01/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of altered protein acetylation in neurodegenerative disease. (2023/01/04) ♡
- Multidisciplinary clinic contributes to the decreasing trend in the number of emergency hospitalizations for amyotrophic lateral sclerosis in Japan. (2023/01/01) ♡
- Reduced-penetrance Huntington's disease-causing alleles with 39 CAG trinucleotide repeats could be a genetic factor of amyotrophic lateral sclerosis. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. T cells in the brain inflammation. (2023/01/01) ♡
- GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. (2023/01/01) ♡
- Network Pharmacology and Molecular Docking to Unveil the Mechanism of Shudihuang against Amyotrophic Lateral Sclerosis. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neurology ethics at the end of life. (2023/01/01) ♡
- Methods to Study Mitochondria: Techniques Used to Study the Effects of Age-Related Diseases Including Alzheimer's. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bulbar Onset Amyotrophic Lateral Sclerosis in an African American Older Adult. (2023/01/01) ♡
- Attitudes of caregivers towards prolonging and shortening life in advanced stages of amyotrophic lateral sclerosis. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis (2023-12-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of Monepantel in Individuals With Motor Neurone Disease (2023-12-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PatientSpot Formerly Known as ArthritisPower (2023-12-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Use of 1 Minute Sit to Stand Test for Physical Capacity and Effort Related Desaturation in Amyotrophic Lateral Sclerosis (2023-12-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real World Testing of a Brain-Computer Interface (2023-12-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exploring Accessible Beauty for Individuals With Upper Extremity Deficits (2023-12-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS (2023-11-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Frequency of SOD1 and C9orf72 Gene Mutations in French ALS (2023-11-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Validation of the "ExSpiron©" in Patients With ALS (2023-11-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients (2023-11-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery (2023-11-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ALS Spinal Cord Gray and White Matter Study (2023-11-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) (2023-10-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD) (2023-10-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Living With a Long-Term Condition Study (2023-10-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) (2023-10-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) (2023-09-29) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.